Zoetis Inc.’s Stock Price Drops to $146.50, Marking a 4.32% Downturn

Zoetis Inc. (ZTS)

146.50 USD -6.61 (-4.32%) Volume: 6.23M

Zoetis Inc.’s stock price stands at 146.50 USD, experiencing a decline of 4.32% this trading session with a trading volume of 6.23M, reflecting a year-to-date percentage change of -25.77%, indicating a turbulent performance in the stock market.

Latest developments on Zoetis Inc.

Zoetis Inc. (NYSE:ZTS) stock price movements have been influenced by a myriad of events recently. The animal health firm saw a dip in stock price due to slower veterinary visits and insider selling, however, it bounced back, trading 0.9% higher and even saw an uptick of 2.2% at one point. Zoetis has also made significant strides in its renewable energy efforts, signing a 12-year Virtual Power Purchase Agreement with Scout Clean Energy. Despite facing EU antitrust scrutiny over rival dog pain medicine and undergoing a change in executive leadership, the company maintains a positive outlook, receiving an ‘Overweight’ rating from Piper Sandler.

A look at Zoetis Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Zoetis has a promising long-term outlook with high scores in Growth and Momentum. This indicates that the company is expected to experience solid growth and positive market momentum in the future. Additionally, the company has a moderate score in Dividend, suggesting a stable dividend payout for investors. However, Zoetis scored lower in Value and Resilience factors, which could pose some challenges in terms of the company’s valuation and ability to withstand economic downturns.

Zoetis Inc. is a global leader in animal health medicines and vaccines, catering to both livestock and companion animals across various regions. With a strong focus on innovation and market expansion, the company has positioned itself as a key player in the industry. Despite facing some hurdles in terms of valuation and resilience, Zoetis’ high scores in Growth and Momentum indicate a positive trajectory for the company’s future performance.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma